Among the flurry of executive orders (EOs) issued by President Trump as his first hundred days in office drew to a close are two taking aim at the high cost of prescription drugs. For many ideas in President Trump’s two executive orders on prescription drug pricing,

Medicare rules, costs, and benefits change every year, but some coming up in 2026 could have a bigger impact on your health and your wallet than usual. Along with having to pay fairly standard price increases,

U.S. President Donald Trump on Friday announced two rules aimed at lowering drug prices for people 65 and older in the Medicare health insurance program, prompting a biotechnology industry group to accuse the president of seeking political revenge.

AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration.

The negotiation program was created by former President Biden’s Inflation Reduction Act, which Democrats passed without a single Republican vote.